ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.

Gregory L Beatty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.